BLC — Bastide le Confort Medical SA Cashflow Statement
0.000.00%
- €197.31m
- €588.24m
- €529.76m
- 83
- 69
- 84
- 95
Annual cashflow statement for Bastide le Confort Medical SA, fiscal year end - June 30th, EUR millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 12.6 | 14.3 | 14.3 | 16.8 | 9.49 |
Depreciation | |||||
Non-Cash Items | 1.01 | 4.25 | 1.81 | 2.77 | -0.995 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -13.6 | 4.97 | -18.7 | 27.4 | 20.9 |
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 47.3 | 74.4 | 56.9 | 106 | 92.7 |
Capital Expenditures | -39.8 | -46.5 | -53.3 | -53.6 | -55.4 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -11.1 | -26.9 | -51.2 | -22.6 | 11.7 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -50.9 | -73.4 | -104 | -76.2 | -43.7 |
Financing Cash Flow Items | -7.73 | -8.42 | -10.5 | -14.9 | -26.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 18.5 | 1.34 | 29.4 | -7.89 | -62.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 14.7 | 2.83 | -18.1 | 21.5 | -13.1 |